| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |